Barry E. Greene
2012 - Alnylam Pharmaceuticals
In 2012, Barry E. Greene earned a total compensation of $1.6M as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 72% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,001 |
|---|---|
| Option Awards | $949,590 |
| Salary | $474,952 |
| Other | $20,665 |
| Total | $1,640,208 |
Greene received $949.6K in option awards, accounting for 58% of the total pay in 2012.
Greene also received $195K in non-equity incentive plan, $475K in salary and $20.7K in other compensation.
Rankings
In 2012, Barry E. Greene's compensation ranked 4,229th out of 11,487 executives tracked by ExecPay. In other words, Greene earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,229 out of 11,487 | 63rd |
Division Manufacturing | 1,472 out of 4,253 | 65th |
Major group Chemicals And Allied Products | 334 out of 1,198 | 72nd |
Industry group Drugs | 204 out of 920 | 78th |
Industry Pharmaceutical Preparations | 157 out of 700 | 78th |
Source: SEC filing on March 10, 2015.
Greene's colleagues
We found four more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2012.
2012
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2012
Akshay Vaishnaw
Alnylam Pharmaceuticals
Chief Medical Officer
2012
Laurence Reid
Alnylam Pharmaceuticals
Senior Vice President and Chief Business Officer
2012
Michael Mason
Alnylam Pharmaceuticals